Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction.
about
In Vivo Rodent Models of Skeletal Muscle Adaptation to Decreased UseAerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and DifferencesSkeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise trainingCellular and molecular mechanisms of muscle atrophyExercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failurePGC-1α promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice.p38 MAPK Participates in Muscle-Specific RING Finger 1-Mediated Atrophy in Cast-Immobilized Rat Gastrocnemius Muscle.Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.SirT1 in muscle physiology and disease: lessons from mouse models.Activated protein synthesis and suppressed protein breakdown signaling in skeletal muscle of critically ill patientsmIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart.Cofilin Phosphorylation Decreased by Serum-free Starvation with Low Glucose in the L6 MyoblastsVentricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failureSkeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.Analysis of skeletal muscle gene expression patterns and the impact of functional capacity in patients with systolic heart failure.Chronic heart failure reduces Akt phosphorylation in human skeletal muscle: relationship to muscle size and functionp300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle.Controlled release of IGF-1 and HGF from a biodegradable polyurethane scaffold.Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophyMolecular and cellular mechanisms of skeletal muscle atrophy: an update.Doxorubicin and NRG-1/erbB4-Deficiency Affect Gene Expression Profile: Involving Protein Homeostasis in Mouse.Angiotensin II as candidate of cardiac cachexiaTNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling.Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration.Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary diseaseMolecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexiaModulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults.Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I.Skeletal muscle abnormalities in chronic heart failure.Metabolic and structural impairment of skeletal muscle in heart failure.Skeletal Muscle Changes in Chronic Cardiac Disease and Failure.Ginsenoside Rg1 prevents starvation-induced muscle protein degradation via regulation of AKT/mTOR/FoxO signaling in C2C12 myotubesSkeletal muscle inflammation and atrophy in heart failure.Exercise capacity, physical activity, and morbidity.Molecular effects of exercise training in patients with cardiovascular disease: focus on skeletal muscle, endothelium, and myocardium.High-Methionine Diet Attenuates Severity of Arthritis and Modulates IGF-I Related Gene Expressions in an Adjuvant Arthritis Rats Model.Formoterol decreases muscle wasting as well as inflammation in the rat model of rheumatoid arthritis.A naturally occurring calcineurin variant inhibits FoxO activity and enhances skeletal muscle regeneration.Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging.Protein catabolism and impairment of skeletal muscle insulin signalling in heart failure.
P2860
Q26753187-03FE2BD0-9C8F-491F-B73A-46ED2F7D982FQ26767412-16DE382A-1877-4550-B302-E476013E8FFBQ26781640-6CA961D4-2843-4C41-8F4D-B4DA17237DC2Q27012762-3A1B0F4C-FB89-4683-8E63-9F987B2CD3D8Q28481996-B190FB74-EAE9-4DB4-8C73-F9AC9B11B9F3Q30427538-6121056D-8EA0-4340-BE2B-77E54AB9BF48Q33574168-EF28CF40-7EC7-4ECF-97D8-C28AA2127F36Q33793116-97678CE4-FF29-4496-9F61-8F32FFDA00C6Q33815408-00F99680-21C8-41F8-8337-53561D16B9DFQ33869877-7845F3C8-9486-41B5-B0E5-24FE4949D640Q34229899-F4350E2A-A507-45E1-B8C0-1E6DE0B388C5Q34409450-2A413FE7-E058-4BD9-BD43-294D2B4AA204Q34590981-CF8F66BB-BB89-464F-A721-1F84BBDE2F1FQ34697114-9DC0F8D6-E60D-492D-9D35-E71299350338Q34781822-748B4EFF-D6DE-48AA-9FF1-F18BD6484AF7Q34785071-7B79D7B4-2734-4C13-A415-EB192C4DB8D0Q35055559-F55524D1-DA0A-44BD-84C4-1AB5B1C845C3Q35432628-83A2F65E-C148-44E4-B523-3B653B163D02Q35787728-DCDFCC7C-E475-4AF7-96DE-4D8A001F9BC3Q36179105-A157CFBF-97B1-4FCF-B6C9-47AEAD42969AQ36219633-5867058A-B256-4A43-901D-AA1468402655Q36445136-689C700C-0293-43F5-95EB-DA1B3AA6DEC7Q36955861-A8B9BC17-C790-48DE-9860-002C97CF9088Q37099711-84F57CE8-26C5-4371-9F6B-64A6495AE172Q37110291-186038E8-ABCC-4744-9965-DA57DE134FDAQ37138465-91CAF499-708A-4261-BFD4-170F7CA8F992Q37257924-ABE5B7F6-3416-4CDE-A0DF-5AEBFF656E52Q37832481-509BB42F-5081-4D86-8CC6-85C44067FFE3Q37994970-3DEFACBB-6F54-44A2-AF74-05E4219B82F6Q38052031-7F742173-C32E-4989-BC98-EE326B2124ECQ38596709-3FF92A07-5858-4EFD-BFBD-6B85E1478A7CQ38638011-C4C52D10-08E7-4E81-9F53-25DE26FCD1E5Q39090262-41F74FC2-3221-49E7-B680-1EFEE76DC087Q39090266-BBF68ABD-324A-4EF8-8E58-E8D707F8EC48Q39286941-A3D15436-0A94-464C-91B1-1FC049874883Q39293713-CCF3580D-0238-4C17-8ED3-7B1DB4DF4BE8Q39721900-1A2F298D-DD0F-4041-94A7-DD88FEA0CE06Q40034287-E4349430-C621-433E-87F5-135D043C82C3Q40445265-40331A1F-E004-47FC-B4AD-C10133F0A16CQ42970762-E6DEA9F6-25E3-4321-A600-B90E0BFA2FEC
P2860
Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Transgenic overexpression of l ...... left-ventricular dysfunction.
@ast
Transgenic overexpression of l ...... left-ventricular dysfunction.
@en
type
label
Transgenic overexpression of l ...... left-ventricular dysfunction.
@ast
Transgenic overexpression of l ...... left-ventricular dysfunction.
@en
prefLabel
Transgenic overexpression of l ...... left-ventricular dysfunction.
@ast
Transgenic overexpression of l ...... left-ventricular dysfunction.
@en
P2093
P1433
P1476
Transgenic overexpression of l ...... left-ventricular dysfunction.
@en
P2093
Cathy MacGillivray
Jennifer Fang
Joe Gannon
Kimberly A Kassik
Mihaela Cupesi
P Christian Schulze
Richard T Lee
P304
P356
10.1161/01.RES.0000179580.72375.C2
P577
2005-07-28T00:00:00Z